ADJUVANT COMBINED SYSTEMIC IMMUNO-CHEMOTHERAPY WITH RECOMBINANT INTERFERON OMEGA AND DOXORUBICIN FIBROSARCOMA INJECTION SITES IN CATS-Reference-Cited by-同舟云学术

ADJUVANT COMBINED SYSTEMIC IMMUNO-CHEMOTHERAPY WITH RECOMBINANT INTERFERON OMEGA AND DOXORUBICIN FIBROSARCOMA INJECTION SITES IN CATS

Published:2024-01-18 Issue: Volume: Page:18-27
ISSN:
Container-title:Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». Part 2. by HNRI «National development» in cooperation with PS of UA. October 2023. - Harbin (China)
language:
Short-container-title:

Author:

Gorinsky Vitaly Ivanovich,Salautin Vladimir Vasilyevich,Pudovkin Nikolay Alexandrovich,Salautina Svetlana Evgenievna

Abstract

This article presents the results of studies aimed at evaluation of the efficacy of combined systemic immunochemotherapy of injection site feline fibrosarcoma in combination with surgical resection of the tumor. The recorded mean duration of the relapse-free period in the combined immunochemotherapy group was 275 days (± 50.9); in the chemotherapy group, it was 178 days (± 26.7).

Publisher

Crossref

Reference54 articles.

1. Banerji, N. and Kanjilal, S. (2006) Somatic alterations of the p53 tumor suppressor gene in vaccine-associated feline sarcoma. American Journal of Veterinary Research 67, 1766-1772

2. Bray, J., Polton, G. (2016): Neoadjuvant and adjuvant chemotherapy combined with anatomical resection of feline injection-site sarcoma: results in 21 cats. Vet Comp Oncol 14, 147-160.

3. Bregazzi V.S., La Rue S.M., McNiel E. et al. (2001) Treatment with a combination of doxorubicm, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000). Journal of the American Veterinary Medical Association 218, 547-550

4. Carminato A, Vascellari M, Marchioro W, Melchiotti E, Mutinelli F (2011): Microchip-associated fibrosarcoma in a cat. Vet Dermatol 22, 565-569.

5. Carneiro CS, de Queiroz GF, Pinto AC, Dagli ML, Matera JM (2019): Feline injection site sarcoma: immunohistochemical characteristics. Feline Med Surg 21(4), 314-321. doi: 10.1177/1098612X18774709. Epub 2018 May 23.